• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

FidoPharm launches fipronil-permethrin combination product

April 17, 2013

PetArmorPro Advanced will be sold over the counter at Walmart.

FidoPharm, a subsidiary of Velcera, has released PetArmorPro Advanced, a topical parasite control product for dogs containing fipronil and permethrin. The parasiticide, designed to kill adult fleas and ticks and to repel fleas, ticks and mosquitoes, will be sold over the counter at Walmart.

The company is positioning the product as a less-expensive alternative to Merial’s Frontline Plus, which is sold by veterinarians. “PetArmorPro Advanced is the ideal solution for pet parents who want to provide their dog with vet-quality flea and tick protection at a much more affordable price,” says Alex Kaufman, president and CEO of FidoPharm, in a company release. “PetArmor’s ‘Protection Guarantee’ promises to protect your dog as well as Frontline Plus or PetArmor will refund the purchase price.”

The PetArmorPro Advanced products are currently available at Walmart and retail at $29 for a 3-month supply.

This announcement comes after a U.S. District Court declared in 2011 that FidoPharm’s PetArmorPlus, along with other Velcera products combining fipronil and methoprene, infringed on the patent covering Merial’s Frontline Plus—that although fipronil’s patent had expired, the fipronil-methoprene combination was still protected. In June 2011, Judge Clay D. Land ordered Velcera to pull from U.S. inventory all products containing the protected combination and present it to Merial for destruction.

Advertisement

FidoPharm also garnered attention from the veterinary industry in March 2012 when it unveiled a generic heartworm preventive, PetTrust Plus (ivermectin-pyrantel), that is available by veterinary prescription only through Walmart and Sam’s Club pharmacies.

Earlier this month, privately held Velcera was sold to Perrigo Co. for approximately $160 million in cash, according to a Velcera press release. Retail sales of the PetArmor franchise exceeded $100 million during calendar year 2012, the brand’s first full year on the market, having launched in April 2011, the release states. According to Perrigo’s website, Perrigo is the world’s largest manufacturer of OTC pharmaceutical products for the store brand market.

Related Content:

Market TrendsBreaking NewsParasitology
Unusual parasite strain kills 4 California sea otters
Unusual parasite strain kills 4 California sea otters
Traditional and holistic treatments for giardia
Traditional and holistic treatments for giardia
Guide offers help for navigating flea and tick season
Guide offers help for navigating flea and tick season

Advertisement

Latest News

An update on copper concerns in pet foods

Dental hacks to make every case more manageable

Q&A with a keynote: Walter Brown, RVTg, VTS, ECC

News wrap-up: This week’s headlines, plus dvm360® launches its first CE podcast

View More Latest News
Advertisement